Jula Inrig, Chief Medical Officer at Travere Therapeutics, Inc. (TVTX), sold 2,509 shares at $9.17 ($24K) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Scheduled sale ($24k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.48 | 2,069 | $20K | 82.9% |
| 2 | $9.17 | 440 | $4K | 17.1% |
| Total | $9.43 avg | 2,509 | $24K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |